Filtered By:
Specialty: Cardiovascular & Thoracic Surgery
Condition: Atrial Fibrillation
This page shows you your search results in order of date. This is page number 4.
Order by Relevance | Date
Total 564 results found since Jan 2013.
Risk of Stroke and Major Bleeding with Vitamin-K Antagonist Use after Mitral Valve Repair
CONCLUSIONS: Our study suggests that VKA after MVr does not reduce risk of cerebral embolic events but is associated with increased risk of major bleeding events.PMID:36223805 | DOI:10.1016/j.athoracsur.2022.09.038
Source: The Annals of Thoracic Surgery - October 12, 2022 Category: Cardiovascular & Thoracic Surgery Authors: Chase R Brown Alexandra E Sperry William G Cohen Jason J Han Fabliha Khurshan Peter Groeneveld Nimesh Desai Source Type: research
Long-term Outcomes of Concomitant Surgical Ablation for Atrial Fibrillation
CONCLUSIONS: Concomitant atrial fibrillation ablation during cardiac surgery is safe, does not increase the rate of perioperative complications, and confers the benefit of long-term survival after cardiac surgery in adults. Atrial fibrillation ablation also improved cardiac surgery patients' long-term survival compared with the matched general atrial fibrillation population.PMID:36216085 | DOI:10.1016/j.athoracsur.2022.09.036
Source: The Annals of Thoracic Surgery - October 10, 2022 Category: Cardiovascular & Thoracic Surgery Authors: Yu-Ting Cheng Yu-Tung Huang Hui-Tzu Tu Yi Hsin Chan Victor Chien-Chia Wu Kuo-Chun Hung Pao-Hsien Chu An-Hsun Chou Shang-Hung Chang Shao-Wei Chen Source Type: research
Surgical Ablation for Atrial Fibrillation During Aortic and Mitral Valve Surgery: A Nationwide Population-Based Cohort Study
There is limited evidence on the effectiveness of surgical AF ablation in reducing mortality or thromboembolic events during aortic/mitral valve (AV/MV) surgery. We evaluated the association of surgical ablation vs. no-ablation with risks of all-cause death and ischemic stroke or systemic embolization (SE) among patients with preoperative atrial fibrillation (AF) undergoing concomitant AV or MV surgery.
Source: The Journal of Thoracic and Cardiovascular Surgery - September 9, 2022 Category: Cardiovascular & Thoracic Surgery Authors: Ho Jin Kim, Ye-Jee Kim, Minju Kim, Jae Suk Yoo, Dae-Hee Kim, Duk-Woo Park, Sung-Ho Jung, Suk Jung Choo, Joon Bum Kim Source Type: research
Apixaban for Anticoagulation after Robotic Mitral Valve Repair
CONCLUSIONS: Anticoagulation with apixaban after minimally invasive robotic MVRep is safe and has similar rates of bleeding and thromboembolism compared to patients treated with warfarin.PMID:35973484 | DOI:10.1016/j.athoracsur.2022.07.045
Source: The Annals of Thoracic Surgery - August 16, 2022 Category: Cardiovascular & Thoracic Surgery Authors: Piotr K Mazur Arman Arghami Shea A Macielak Scott D Nei Jason K Viehman Katherine S King Richard C Daly Juan A Crestanello Hartzell V Schaff Joseph A Dearani Source Type: research
Impact of Procedure Volume on the Outcomes of Surgical Aortic Valve Replacement
CONCLUSION: Patients treated in very low volume centers (≤25 operations/year) had a similar risk regarding in-hospital mortality and most complications compared with very high-volume centers (>100 operations/year). Only in the case of acute kidney injury, very high-volume centers showed better outcomes than very low volume centers. Therefore, surgical aortic valve replacement can be performed safely independent of case volume.PMID:35917823 | DOI:10.1055/s-0042-1754352
Source: The Thoracic and Cardiovascular Surgeon - August 2, 2022 Category: Cardiovascular & Thoracic Surgery Authors: Vera Oettinger Klaus Kaier Constantin von Zur M ühlen Manfred Zehender Christoph Bode Friedhelm Beyersdorf Peter Stachon Wolfgang Bothe Source Type: research
